Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00028639 · ClinicalTrials.gov registry record · Phase 2
PS-341 in Treating Women With Metastatic Breast Cancer
A Phase 2 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00028639: Completed Phase 2 study, sponsored by Northwestern University.
NCT00028639 is a Phase 2 study that has completed, run by Northwestern University. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00028639, a Phase 2 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: PS-341 may stop the growth of tumor cells by blocking the enzymes necessary for cancer cell growth. PURPOSE: Phase II trial to study the effectiveness of PS-341 in treating women who have metastatic breast cancer.
Interventions
- DRUG bortezomib
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-08 |
| Est. Completion | 2003-11 |
| Phase | Phase 2 |
What the finished NCT00028639 record still lists
NCT00028639 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which bortezomib is the first listed.
NCT00028639 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00028639 about?
NCT00028639 is a clinical study titled "PS-341 in Treating Women With Metastatic Breast Cancer". RATIONALE: PS-341 may stop the growth of tumor cells by blocking the enzymes necessary for cancer cell growth. PURPOSE: Phase II trial to study the effectiveness of PS-341 in treating women who have metastatic breast cancer.
What is the current status of trial NCT00028639?
This trial is currently completed. It is a Phase 2 study. The study started on 2001-08. Estimated completion is 2003-11.
What interventions are being tested in trial NCT00028639?
The interventions under investigation include: bortezomib (DRUG).
Who is sponsoring clinical trial NCT00028639?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia